RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer

Harnessing RNA interference (RNAi) to silence aberrant gene expression is an emerging approach in cancer therapy. Selective inhibition of an overexpressed gene via RNAi requires a highly efficacious, target-specific short interfering RNA (siRNA) and a safe and efficient delivery system. We have deve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seth, Shaguna, Matsui, Yoshiyuki, Fosnaugh, Kathy, Liu, Yan, Vaish, Narendra, Adami, Roger, Harvie, Pierrot, Johns, Rachel, Severson, Gregory, Brown, Tod, Takagi, Akihide, Bell, Susan, Chen, Yan, Chen, Feng, Zhu, Tianying, Fam, Renata, Maciagiewicz, Iwona, Kwang, Erin, McCutcheon, Michael, Farber, Ken, Charmley, Patrick, Houston Jr., Michael E, So, Alan, Templin, Michael V, Polisky, Barry
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098637/
https://ncbi.nlm.nih.gov/pubmed/21364537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados